253 related articles for article (PubMed ID: 17449234)
1. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
[TBL] [Abstract][Full Text] [Related]
2. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD.
Skyba P; Kluchova Z; Joppa P; Petrasova D; Tkacova R
Med Sci Monit; 2009 Oct; 15(10):CR528-533. PubMed ID: 19789512
[TBL] [Abstract][Full Text] [Related]
3. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
4. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
5. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
6. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
7. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and airway inflammation in severe exacerbations of COPD.
Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
[TBL] [Abstract][Full Text] [Related]
10. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
11. [Systemic inflammation among stable ex smokers with chronic obstructive pulmonary disease].
Morales S A; Dreyse D J; Díaz P O; Saldías P F; Carrasco M; Lisboa B C
Rev Med Chil; 2010 Aug; 138(8):957-64. PubMed ID: 21140052
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
13. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
[TBL] [Abstract][Full Text] [Related]
14. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
15. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
[TBL] [Abstract][Full Text] [Related]
17. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
18. Increased serum inflammatory markers in the absence of clinical and skeletal muscle inflammation in patients with chronic obstructive pulmonary disease.
Piehl-Aulin K; Jones I; Lindvall B; Magnuson A; Abdel-Halim SM
Respiration; 2009; 78(2):191-6. PubMed ID: 19270439
[TBL] [Abstract][Full Text] [Related]
19. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
20. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
Komnata K
Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
